Sabby Management, LLC Plus Therapeutics, Inc. Transaction History

Sabby Management, LLC

  • $130,000
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$1.05 - $2.85 $245,830 - $667,253
-234,124 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.99 - $3.23 $239,842 - $389,292
120,524 Added 106.1%
234,124 $562,000
Q3 2019

Nov 15, 2019
BUY
$3.3 - $19.25 $374,880 - $2.19 Million
113,600 New
113,600 $389,000

About PLUS THERAPEUTICS, INC.

PSTV Quotes by TradingView
  • Ticker PSTV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,601,400
  • Market Cap $36.6M
  • Description
  • Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...
More about PSTV
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email